Clinical Trials Directory

Trials / Conditions / Recurrent WHO Grade III Glioma

Recurrent WHO Grade III Glioma

8 registered clinical trials studyying Recurrent WHO Grade III Glioma — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingCombination Therapy for the Treatment of Diffuse Midline Gliomas
NCT05009992
University of California, San FranciscoPhase 2
Active Not RecruitingChimeric Antigen Receptor (CAR) T Cells With a Chlorotoxin Tumor-Targeting Domain for the Treatment of MMP2+ R
NCT04214392
City of Hope Medical CenterPhase 1
CompletedBGB-290 and Temozolomide in Treating Patients With Recurrent Gliomas With IDH1/2 Mutations
NCT03914742
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase 1 / Phase 2
Active Not RecruitingBGB-290 and Temozolomide in Treating Isocitrate Dehydrogenase (IDH)1/2-Mutant Grade I-IV Gliomas
NCT03749187
University of California, San FranciscoPhase 1
CompletedFluoroethyltyrosine for Evaluation of Intracranial Neoplasms
NCT04044937
Thomas HopePhase 2
RecruitingSerial MR Imaging and MR Spectroscopic Imaging for the Characterization of Lower Grade Glioma
NCT04540107
Susan ChangPhase 1
Active Not RecruitingCarboxylesterase-Expressing Allogeneic Neural Stem Cells and Irinotecan Hydrochloride in Treating Patients Wit
NCT02192359
City of Hope Medical CenterPhase 1
Active Not RecruitingGenetically Modified T-cells in Treating Patients With Recurrent or Refractory Malignant Glioma
NCT02208362
City of Hope Medical CenterPhase 1